Trial intelligence / Profile preview

Cyclophosphamide vs Megestrol in Palliative Cancer

NCT00420563Phase 2Completed

Sponsor
Centre Oscar Lambret
Start
Sep 2009
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cyclophosphamide in cancer, sponsored by Centre Oscar Lambret. Started Sep 2009; status: completed.

02

Drugs

cyclophosphamide
03

Conditions

cancer

Beyond the preview

Go deeper on NCT00420563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00420563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call